Prosena to be acquired By: MarketMinute.com Stock News November 24, 2014 at 15:55 PM EST BioMarin Pharmaceutical Inc. will pay a premium of approximately $840 million to buy Prosena Holding N.V. (Nasdaq: RNA) sending the stock price leaping $7.16 to close at $18.60.